Presentation is loading. Please wait.

Presentation is loading. Please wait.

Clofarabine Salvage Therapy Prior To Allogeneic Hematopoietic Stem Cell Transplantation In Patients With Relapsed Or Refractory AML – Results Of The Bridge.

Similar presentations


Presentation on theme: "Clofarabine Salvage Therapy Prior To Allogeneic Hematopoietic Stem Cell Transplantation In Patients With Relapsed Or Refractory AML – Results Of The Bridge."— Presentation transcript:

1 Clofarabine Salvage Therapy Prior To Allogeneic Hematopoietic Stem Cell Transplantation In Patients With Relapsed Or Refractory AML – Results Of The Bridge Trial – by Jan Moritz Middeke, Regina Herbst, Stefani Parmentier, Gesine Bug, Mathias Hänel, Gernot Stuhler, Kerstin Schäfer-Eckart, Wolf Rösler, Stefan A. Klein, Wolfgang A Bethge, Ulrich Bitz, Nael Alakel, Markus Schaich, Anke Morgner, Stefan Pursche, Michael Kramer, Uwe Platzbecker, Christoph Röllig, Christian Thiede, Gerhard Ehninger, and Martin Bornhäuser Blood Volume 122(21): November 15, 2013 ©2013 by American Society of Hematology

2 DFS. DFS Jan Moritz Middeke et al. Blood 2013;122:304
©2013 by American Society of Hematology

3 Time to HSCT according to donor status at the time of study enrollment.
Jan Moritz Middeke et al. Blood 2013;122:304 ©2013 by American Society of Hematology


Download ppt "Clofarabine Salvage Therapy Prior To Allogeneic Hematopoietic Stem Cell Transplantation In Patients With Relapsed Or Refractory AML – Results Of The Bridge."

Similar presentations


Ads by Google